Health

CStone successfully hosted the first U.S. R&D Day in New York

* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...

2020-01-24 08:03 2532

YiduCloud founder, Gong Rujing addresses on shaping the future of health and healthcare at Davos 2020

DAVOS, Switzerland, Jan. 22, 2020 /PRNewswire/ -- "We focus so much on 'sickcare', and we do not focus enough on 'healthcare'. Our mission is to provide more accessible and affordable personal care to the public by using artificial intelligence and data technologies," said Gong Rujing, founder an...

2020-01-23 11:22 1804

Isagenix International Acquires Zija International

Companies share common goals, cultures, and missions focused on improving world health GILBERT, Arizona, Jan. 22, 2020 /PRNewswire/ -- Isagenix International, a global health and wellness company providing nutrition and lifestyle solutions, has announced its acquisition of Zija International, a ...

2020-01-22 23:30 1865

Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Includes 8 Oral Presentations and Award of Best Clinical Abstract ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (...

2020-01-21 20:00 947

Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody

SUZHOU and HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) appl...

2020-01-21 00:00 885

TenNor Therapeutics Received FDA Orphan Drug Designation

SUZHOU, China, Jan. 20, 2020 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devices such as prosthetic joints, central venous catheters and artificial hear...

2020-01-20 20:50 936

Milk without the cow: TurtleTree Labs, world's first company producing milk from cells, secures pre-seed funding

* The pre-seed round was led by Lever VC with K2 Global and KBW Ventures backing TurtleTree Labs * TurtleTree is the world's first company using technology to create real milk from animal cells, with no animal needed. * The raise will be used to onboard more scientists to the TurtleTree team...

2020-01-20 15:37 2089

KT and Samsung Medical Center to Build 5G Smart Hospital

* World's First Application of 5G Technology in Medical Practice * Sync Cams Share Real-Time HD Video Footage of Surgery for Teaching * 5G Network Base Made Secure for Medical Service Development * Enterprise-Dedicated 5G Network Protects Private Medical Info from Hacking SEOUL, South Korea...

2020-01-20 13:47 9114

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

SEONGNAM, South Korea, Jan. 19, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared ...

2020-01-20 10:44 1189

111 Unveils New Video on The Impact of Chinese Policies to Medical Industry

SHANGHAI, Jan. 19, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today,The Impact of Chinese Policies to Medical Industry,...

2020-01-19 18:00 18324

Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019

NANPING, China, Jan. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2019. The financial results...

2020-01-17 21:00 19087

111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference

SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation inChina's Healthcare and Pharmaceutical Industry" at the 3...

2020-01-17 20:00 7510

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...

2020-01-16 21:00 6095

"Every Person Deserves the Chance to Live a Healthy and Productive Life" -- 2020 BUTTON Healthcare Cross-Border Partnering Summit -- From Globe to Asia

HEFEI, China, Jan. 16, 2020 /PRNewswire/ -- On the morning of January 13, 2020 (Pacific Time), the 38th J.P. Morgan Healthcare Conference opened in San Francisco as scheduled. At the same time, the "BUTTON Healthcare Cross-Border Partnering Summit - From Globe toAsia" was grandly held at the Merc...

2020-01-16 16:11 1103

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany

* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-01-16 10:39 17915

Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"

SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...

2020-01-16 07:30 1446

GenScript and Genopis Enter Into Strategic Partnership Agreement for Manufacture Service of GMP Plasmids

NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the manufacturing service of GMP Plasmids with Genopis, Inc., a company that specializes in plasmid D...

2020-01-16 01:00 2024

Medit Responds to Ongoing Patent Infringement Lawsuit in Germany

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Medit today announced that there is an ongoing lawsuit inGermany in relation to European Patent no. 2 568 870 B1. The Regional Court of Duesseldorf in Germany rendered a judgment on January 9, 2020 (docket number 4c O 11/19), holding that Medit's...

2020-01-14 23:26 1681

Volition Develops a New Improved Nu.Q™ Assay Format

AUSTIN, Texas, Jan. 13, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided an update on its Nu Q™ Clinical Assays which use a magnetic particle-based assay format. Volition has completely re-engineered its Nu.Q™ assays leading to a step-change improvement in...

2020-01-13 22:00 16112

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...

2020-01-13 22:00 6426
1 ... 261262263264265266267 ... 273